TTK 抑制剂 OSU13 通过激活瘤 STING 来促进免疫治疗反应
Vijaya Bharti1,2,3, Amrendra Kumar1,2,3, Yinchong Wang1,2,3,4
1Department of Pathology.
JCI insight
|June 20, 2024
概括
TTK抑制剂OSU13通过诱导细胞循环停止和DNA损伤,激活cGAS/STING通路,表现出抗瘤作用. 将OSU13与免疫疗法结合起来,可以增强STING专业的癌症的抗瘤活性和存活率.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- TTK螺旋组装检查点酶是一种有前途的癌症标.
- 了解TTK抑制剂的抗瘤机制对于临床开发至关重要.
研究的目的:
- 为了探索TTK抑制剂OSU13.13的抗瘤机制.
- 确定OSU13.13临床开发的战略.
主要方法:
- 使用癌细胞系,患者衍生器官和小鼠模型进行临床前研究.
- 评估了细胞循环停止,衰老,细胞亡,DNA损伤和cGAS/STING通路的激活.
- 研究了OSU13与抗PD-1检查点封锁的组合.
主要成果:
- OSU13在黑色素瘤,结肠癌和乳腺癌中表现出抗瘤活性,诱导G2细胞周期停止,衰老和亡.
- 治疗OSU13导致DNA损伤和微核的形成,激活cGAS/STING通路.
- 与OSU13和抗PD-1的联合治疗导致显著的瘤抑制和改善的生存率,依赖于STING和CD8+T细胞.
结论:
- 通过DNA损伤和免疫路径激活,OSU13表现出强大的临床前抗瘤活性.
- 将TTK抑制剂与免疫疗法结合起来,特别是在STING熟练的瘤中,是癌症治疗的一个有前途的策略.
更多相关视频
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Cytotoxic T Cells-mediated Immune Response
889
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
889
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


